Publications
- Ophthalmology Times (logo): Ophthalmology Times® is a physician-driven media brand that presents cutting-edge advancements and analysis from around the world in surgery, clinical diagnosis, therapeutics, device technology, imaging, and gene therapy to elevate the delivery of progressive eye health from physician to patient.
- Clicking here leads to:
https://www.ophthalmologytimes.com/journals/ophthalmology-times-journal
- Ophthalmology Times Europe (logo): Ophthalmology Times Europe® is the independent source for current developments and best practices in European ophthalmology. It is the balanced and unbiased forum for ophthalmologists to communicate practical experience, clinical knowledge, discoveries and applications, thereby promoting improvements to medical practice and patient health.
- Clicking here leads to:
https://europe.ophthalmologytimes.com/
- Modern Retina (logo): Modern Retina strives toempower relevant clinical and surgical connections through balanced, current, and immersive content aimed at retina specialists.
- Clicking here leads to:
https://www.modernretina.com/
- Optometry Times (logo): Optometry Times® delivers easily digested, practical information by ODs for ODs. This information can be immediately applied to improve the clinical experience of the next patient in your chair as well as your practice performance. In partnering with our readers, Optometry Times® provides data, analysis, tools, and resources that are available whenever and wherever our readers want them.
- Clicking here leads to:
https://www.optometrytimes.com/
- Supplements
- Clicking here leads to:
https://www.ophthalmologytimes.com/journals/supplements-and-featured-publications
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
What ‘I’m Fine’ Really Means: An Open Letter from a Thyroid Eye Disease (TED) Patient
2
Opus Genetics has Type B RMAT meeting with FDA for its gene therapy candidate, OPGx-LCA5
3
PolyActiva and RareSight partner to develop treatments for rare pediatric retinal diseases
4
AAO 2025: A study of retinal vasculitis events with intravitreal agents
5
.png "Optometry Times"){kind=logo}
